OBJECTIVE: To ascertain the incidence of testicular microlithiasis (TM) in boys with McCune-Albright syndrome (MAS). STUDY DESIGN: Study population consisted of 8 boys with MAS whose medical records were reviewed with emphasis on their past genitourinary histories. All of the boys underwent a clinical and ultrasonographic (US) scanning of the scrotal and inguinal regions. US results in boys with MAS were compared with those obtained in two control populations consisting of 20 healthy subjects and 12 boys with idiopathic and untreated central precocious puberty (CPP). RESULTS: Clinical examination revealed urological abnormalities in no patients, whereas US showed a typical picture of TM in 5 of 8 boys. TM was observed in none of the subjects belonging to control populations (v=15.2 and 11.3, respectively; P <.001). CONCLUSIONS: In a series of 8 boys with MAS we demonstrated a high prevalence (62%) of TM that was associated with neither malignant nor nonmalignant conditions. This finding is unlikely to be only occasional, considering the very low prevalence of TM reported until now in healthy children and young adults and in our results in control populations. TM may be another marker for MAS.
OBJECTIVE: To ascertain the incidence of testicular microlithiasis (TM) in boys with McCune-Albright syndrome (MAS). STUDY DESIGN: Study population consisted of 8 boys with MAS whose medical records were reviewed with emphasis on their past genitourinary histories. All of the boys underwent a clinical and ultrasonographic (US) scanning of the scrotal and inguinal regions. US results in boys with MAS were compared with those obtained in two control populations consisting of 20 healthy subjects and 12 boys with idiopathic and untreated central precocious puberty (CPP). RESULTS: Clinical examination revealed urological abnormalities in no patients, whereas US showed a typical picture of TM in 5 of 8 boys. TM was observed in none of the subjects belonging to control populations (v=15.2 and 11.3, respectively; P <.001). CONCLUSIONS: In a series of 8 boys with MAS we demonstrated a high prevalence (62%) of TM that was associated with neither malignant nor nonmalignant conditions. This finding is unlikely to be only occasional, considering the very low prevalence of TM reported until now in healthy children and young adults and in our results in control populations. TM may be another marker for MAS.
Authors: Margaret Zacharin; Anurag Bajpai; Chung Wo Chow; Anthony Catto-Smith; Constantine Stratakis; Michelle W Wong; Rodney Scott Journal: J Med Genet Date: 2011-02-28 Impact factor: 6.318
Authors: M F Campagnoli; A Pucci; E Garelli; A Carando; C Defilippi; R Lala; G Ingrosso; I Dianzani; M Forni; U Ramenghi Journal: J Clin Pathol Date: 2006-04 Impact factor: 3.411
Authors: Alison M Boyce; William H Chong; Thomas H Shawker; Peter A Pinto; W Marsten Linehan; Nisan Bhattacharryya; Maria J Merino; Frederick R Singer; Michael T Collins Journal: J Clin Endocrinol Metab Date: 2012-06-28 Impact factor: 5.958
Authors: Malene Roland Pedersen; Søren Rafael Rafaelsen; Henrik Møller; Peter Vedsted; Palle Jörn Osther Journal: Int Urol Nephrol Date: 2016-03-23 Impact factor: 2.370
Authors: Peter J O'Shaughnessy; Ana Monteiro; Guido Verhoeven; Karl De Gendt; Margaret H Abel Journal: Reprod Biol Endocrinol Date: 2009-08-27 Impact factor: 5.211